| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | COMPARATIVE ANTIPLATELET AGGREGATION EFFECT OF TWO CLOPIDOGREL PRODUCTS UNDER STEADY STATE CONDITION IN HEALTHY VOLUNTEERS | S. Tiamkao N. Nakkam S. Kanjanawart W. Tassaneeyakul |
2014 | ||||
| 2. | Genetic Determinants of Antiplatelet Aggregation Response to Clopidogrel Under Steady State Condition | N. Nakkam S. Kanjanawart S. Tiamkao W. Tassaneeyakul |
2015 | ||||
| 3. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers | Tassaneeyakul, W. Nakkam, N. Tiamkao, S. Kanjanawart, S. Phunikhom, K. Tiamkao, S. Vannaprasaht, S. Tassaneeyakul, W. |
2017 | ||||
| 4. | Comparison between the HLA-B ∗ 58: 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions | Nakkam, N Chumworathayi, P. Kanjanawart, S. Tassaneeyakul, W. |
2017 | ||||
| 5. | Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B ∗ 13:01 allele in the Thai population | Nakkam, N. Wattanakrai, P. Jantararoungtong, T. Mahakkanukrauh, A. Tassaneeyakul, W. |
2017 | ||||
| 6. | Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population | Tassaneeyakul, W. Nakkam, N. Chumworathayi, P. Chaiyakunapruk, N. Sawanyawisuth, K.I. Tassaneeyakul, W. |
2017 | ||||
| 7. | HLA pharmacogenetic markers of drug hypersensitivity in a Thai population | Nakkam, N Kanjanawart, S. Kongpan, T. Tassaneeyakul, W. |
2018 | ||||
| 8. | HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians | Nakkam, N | 2019 | ||||
| 9. | The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label | Nakkam, N | 2019 | ||||
| 10. | Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes | Puangpetch, A. Nakkam, N. Kanjanawart, S. Kongpan, T. Chumworathayi, P. Tassaneeyakul, W. Chantràtita, W. |
2020 | ||||
| 11. | Prevalence of CYP2C19, CYP3A4 and FMO3 genetic polymorphisms in healthy northeastern Thai volunteers | Kanjanawart, S. Nakkam, N. Tassaneeyakul, W. |
2020 | ||||
| 12. | Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01 | Tassaneeyakul, W. Nakkam, N. |
2021 | ||||
| 13. | Considerations for cross-reactivity between vancomycin and other glycopeptides | Nakkam, N. | 2021 | ||||
| 14. | Cross-reactivity between vancomycin, teicoplanin, and telavancin in patients with HLA-A∗32:01–positive vancomycin-induced DRESS sharing an HLA class II haplotype | Nakkam, N. | 2021 | ||||
| 15. | HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients | Nakkam, N. Mahakkanukrauh, A. Jantararoungtong, T. Tassaneeyakul, W. |
2021 | ||||
| 16. | Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations | Khaeso, K. Komvilaisak, P. Chainansamit, S.O. Nakkam, N. Puangpetch, A. Tassaneeyakul, W. Chaiyakunapruk, N. |
2021 | ||||
| 17. | Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians | Tassaneeyakul, W. Nakkam, N. Chantràtita, W. |
2021 | ||||
| 18. | Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions | Nakkam, N. Saksit, N. Konyoung, P. Amornpinyo, W. Khunarkornsiri, U. Purimart, D. Pattanacheewapull, O. Naewla, T. Wattanachai, P. Khaeso, K. Chumworathayi, P. Tassaneeyakul, W. |
2022 | ||||
| 19. | Development of label-free electrochemical impedance spectroscopy for the detection of HLA-B*15:02 and HLA-B*15:21 for the prevention of carbamazepine-induced Stevens-Johnson syndrome | Nakkam, N. Tassaneeyakul, W. Kaset, C. |
2022 | ||||
| 20. | Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine | Nakkam, N. Konyoung, P. Tiamkao, S. Khaeso, K. Jorns, T.P. Chumworathayi, P. Tassaneeyakul, W. |
2022 | ||||
| 21. | NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine | Khaeso, K. Komvilaisak, P. Chainansamit, S.O. Nakkam, N. Kanjanawart, S. Vannaprasaht, S. Tassaneeyakul, W. |
2022 | ||||
| 22. | Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions | Wattanachai, P. Amornpinyo, W. Konyoung, P. Purimart, D. Khunarkornsiri, U. Pattanacheewapull, O. Tassaneeyakul, W. Nakkam, N. |
2023 | ||||
| 23. | Cost-effectiveness analysis of HLA-B*13:01 screening for the prevention of co-trimoxazole-induced severe cutaneous adverse reactions among HIV-infected patients in Thailand | Kategeaw, W. Nakkam, N. Kiertiburanakul, S. |
2023 | Count | 21 | 0 | 2 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers | Tassaneeyakul, W. Nakkam, N. Tiamkao, S. Kanjanawart, S. Phunikhom, K. Tiamkao, S. Vannaprasaht, S. Tassaneeyakul, W. |
2017 |
International Journal of Clinical Pharmacology and Therapeutics 2 (55), pp. 177-185 |
||||||||
| 2. | Comparison between the HLA-B ∗ 58: 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions | Nakkam, N Chumworathayi, P. Kanjanawart, S. Tassaneeyakul, W. |
2017 |
Journal of Immunology Research (2017), pp. |
||||||||
| 3. | Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B ∗ 13:01 allele in the Thai population | Nakkam, N. Wattanakrai, P. Jantararoungtong, T. Mahakkanukrauh, A. Tassaneeyakul, W. |
2017 |
Pharmacogenetics and Genomics 12 (27), pp. 429-437 |
||||||||
| 4. | Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population | Tassaneeyakul, W. Nakkam, N. Chumworathayi, P. Chaiyakunapruk, N. Sawanyawisuth, K.I. Tassaneeyakul, W. |
2017 |
Pharmacogenetics and Genomics 7 (27), pp. 255-263 |
||||||||
| 5. | HLA pharmacogenetic markers of drug hypersensitivity in a Thai population | Nakkam, N Kanjanawart, S. Kongpan, T. Tassaneeyakul, W. |
2018 |
Frontiers in Genetics AUG (9), pp. |
||||||||
| 6. | HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians | Nakkam, N | 2019 |
Clinical Pharmacology and Therapeutics 2 (105), pp. 476-485 |
||||||||
| 7. | The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label | Nakkam, N | 2019 |
Clinical Pharmacology and Therapeutics 1 (105), pp. 112-120 |
||||||||
| 8. | Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes | Puangpetch, A. Nakkam, N. Kanjanawart, S. Kongpan, T. Chumworathayi, P. Tassaneeyakul, W. Chantràtita, W. |
2020 |
Clinical Pharmacology and Therapeutics 5 (108), pp. 1078-1089 |
||||||||
| 9. | Prevalence of CYP2C19, CYP3A4 and FMO3 genetic polymorphisms in healthy northeastern Thai volunteers | Kanjanawart, S. Nakkam, N. Tassaneeyakul, W. |
2020 |
ScienceAsia 4 (46), pp. 397-402 |
||||||||
| 10. | Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01 | Tassaneeyakul, W. Nakkam, N. |
2021 |
Frontiers in Immunology (12), pp. |
||||||||
| 11. | Considerations for cross-reactivity between vancomycin and other glycopeptides | Nakkam, N. | 2021 |
Journal of Allergy and Clinical Immunology: In Practice 8 (9), pp. 3233 |
||||||||
| 12. | Cross-reactivity between vancomycin, teicoplanin, and telavancin in patients with HLA-A∗32:01–positive vancomycin-induced DRESS sharing an HLA class II haplotype | Nakkam, N. | 2021 |
Journal of Allergy and Clinical Immunology 1 (147), pp. 403-405 |
||||||||
| 13. | HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients | Nakkam, N. Mahakkanukrauh, A. Jantararoungtong, T. Tassaneeyakul, W. |
2021 |
Frontiers in Immunology (12), pp. |
||||||||
| 14. | Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations | Khaeso, K. Komvilaisak, P. Chainansamit, S.O. Nakkam, N. Puangpetch, A. Tassaneeyakul, W. Chaiyakunapruk, N. |
2021 |
Frontiers in Pharmacology (12), pp. |
||||||||
| 15. | Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians | Tassaneeyakul, W. Nakkam, N. Chantràtita, W. |
2021 |
Journal of Allergy and Clinical Immunology 4 (147), pp. 1402-1412 |
||||||||
| 16. | Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions | Nakkam, N. Saksit, N. Konyoung, P. Amornpinyo, W. Khunarkornsiri, U. Purimart, D. Pattanacheewapull, O. Naewla, T. Wattanachai, P. Khaeso, K. Chumworathayi, P. Tassaneeyakul, W. |
2022 |
Drug Metabolism and Pharmacokinetics (47), pp. |
||||||||
| 17. | Development of label-free electrochemical impedance spectroscopy for the detection of HLA-B*15:02 and HLA-B*15:21 for the prevention of carbamazepine-induced Stevens-Johnson syndrome | Nakkam, N. Tassaneeyakul, W. Kaset, C. |
2022 |
Analytical Biochemistry (658), pp. |
||||||||
| 18. | Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine | Nakkam, N. Konyoung, P. Tiamkao, S. Khaeso, K. Jorns, T.P. Chumworathayi, P. Tassaneeyakul, W. |
2022 |
British Journal of Clinical Pharmacology 2 (88), pp. 773-786 |
||||||||
| 19. | NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine | Khaeso, K. Komvilaisak, P. Chainansamit, S.O. Nakkam, N. Kanjanawart, S. Vannaprasaht, S. Tassaneeyakul, W. |
2022 |
Drug Metabolism and Pharmacokinetics (43), pp. |
||||||||
| 20. | Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions | Wattanachai, P. Amornpinyo, W. Konyoung, P. Purimart, D. Khunarkornsiri, U. Pattanacheewapull, O. Tassaneeyakul, W. Nakkam, N. |
2023 |
Frontiers in Pharmacology (14), pp. |
||||||||
| 21. | Cost-effectiveness analysis of HLA-B*13:01 screening for the prevention of co-trimoxazole-induced severe cutaneous adverse reactions among HIV-infected patients in Thailand | Kategeaw, W. Nakkam, N. Kiertiburanakul, S. |
2023 |
Journal of Medical Economics 1 (26), pp. 1330-1341 |
||||||||
| Title | Authors | Year | Journal title |
|---|
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | COMPARATIVE ANTIPLATELET AGGREGATION EFFECT OF TWO CLOPIDOGREL PRODUCTS UNDER STEADY STATE CONDITION IN HEALTHY VOLUNTEERS | S. Tiamkao N. Nakkam S. Kanjanawart W. Tassaneeyakul |
2014 |
CEREBROVASCULAR DISEASES (37.0), pp. 341.0-341.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 2. | Genetic Determinants of Antiplatelet Aggregation Response to Clopidogrel Under Steady State Condition | N. Nakkam S. Kanjanawart S. Tiamkao W. Tassaneeyakul |
2015 |
PUBLIC HEALTH GENOMICS (18.0), pp. 11.0-11.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title |
|---|
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ |
|---|